Clinical Trial Update: Ambisome® Preemptive Treatment of Multiple Candida Colonization in Sepsis Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating preemptive treatment with Ambisome (liposomal amphotericin B) to prevent Candida colonization in sepsis patients. Curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Candida Infections
• Sepsis

Drugs mentioned

• AMBISOME (AMPHOTERICIN B)

Snippet

Sponsor: Fovea | Conditions: Sepsis, Candida | Phase 4 | Status: UNKNOWN